Cell: 626-993-4397
Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC.
His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells.
He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010).
He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS.
He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.
Information:
Hazardous Materials,
Oncology,
Toxic Exposures,
Toxic Tort,
Toxicology,
Cell: 626-993-4397
Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC.
His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells.
He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010).
He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS.
He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.